Adam Lenkowsky

For over two decades, I’ve had the privilege to grow and innovate alongside our great teams at Bristol Myers Squibb. Together, we have expanded the boundaries of science for the benefit of patients across the globe.  Over the years, I’ve been consistently reminded of the importance of the work we do by who we are working for – the patients whose lives are impacted by the treatments we develop. This has served as a beacon in cultivating a diverse and inclusive culture that prioritizes its people, performance, and above all else, patients. As Executive Vice President and Chief Commercialization Officer, I am privileged to lead our Commercialization organization globally, with responsibility for driving growth across our company’s key franchises including Oncology, Hematology, Cardiovascular, Immunology and Cell Therapy to bring our transformative medicines to patients around the world. In this unique moment in time, we have a great opportunity ahead of us to harness the pace of science to do more for patients than ever previously possible, fueling future innovation and growth.